Photo by diabetesmagazijn from unsplash
To determine the association with cardiovascular (CV) outcomes of sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors compared with dipeptidyl peptidase‐4 (DPP‐4) inhibitors in patients with type 2 diabetes (T2D) and chronic kidney disease… Click to show full abstract
To determine the association with cardiovascular (CV) outcomes of sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors compared with dipeptidyl peptidase‐4 (DPP‐4) inhibitors in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD).
Keywords:
dipeptidyl peptidase;
chronic kidney;
glucose transporter;
cardiovascular outcomes;
sodium glucose;
inhibitors patients
Journal Title: Diabetes
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!